{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-022757","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2023-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.178097+00:00","generated_at":"2026-06-13T20:41:34.046963+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cardiff Oncology grants 40,032 stock options to new employee as inducement","bullets":["Non-qualified stock options to purchase 40,032 shares granted to one new employee on June 20, 2023.","Exercise price of $1.56 per share equals closing price on grant date.","Options vest over 4 years: 25% at 1-year anniversary, then monthly over remaining 36 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-022757","json":"https://secwatch.observer/filing/0001628280-23-022757.json","markdown":"https://secwatch.observer/filing/0001628280-23-022757.md","text":"https://secwatch.observer/filing/0001628280-23-022757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022757/0001628280-23-022757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023022757/crdf-20230620.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T20:41:34.046963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}